Pooled results from two 12-week clinical trials involving more than 600 patients showed that 48.1% of patients treated with quetiapine fumarate achieved a response [defined as >50% decrease from ...

September 7, 2011 (Paris, France) — Once-daily extended-release quetiapine fumarate monotherapy is significantly more effective than placebo in treating depressive symptoms in elderly patients ...

Quetiapine fumarate is an atypical antipsychotic and the tablets, for oral use, were first approved in the U.S. in 1997. The medication is widely prescribed by healthcare providers in psychiatry ...